North America Cell Based Assays Market, By Type (Cell Viability Assay, Cytotoxicity Assay, Cell Death Assay, Cell Proliferation Assay and Others), Product and Services (Consumables, Services, Instruments and Software), Technology (Flow Cytometry, High Throughput Screening, High Content Screening and Label Free Detection), Application (Drug Discovery, Basic Research and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutions, Government Organizations and Others), Distribution Channel (Direct and Indirect), Country (U.S., Canada and Mexico) Industry Trends and Forecast to 2028.
Market Analysis and Insights of Cell Based Assays Market
Rising prevalence of chronic and infectious diseases globally and increasing research and development proficiencies have led to the rise in cell based assays market value. Data Bridge Market Research analyses that the cell based assays market will exhibit a CAGR of around 10.68% for the forecast period of 2021-2028.
Cell based assays is a technology that is used for cytotoxic and biological testing and these assays rely on reporter gene assays, which have high sensitivity. Cell based assays technology is used to conduct research and development activities or experiments using live cells. It is a homogeneous method that is used to detect the cell toxicity, proliferation, production of markers, activation of specific signalling pathways, motility, changes in morphology and other parameters.
Growing private and public funding for cell-based research, rising adoption of high-throughput screening methods and growing preference for cell-based assays in drug discovery will propel the growth in the demand for cell based assays. Rising expenditure to develop healthcare infrastructure coupled with growth in the adoption of label-free cell-based assays will further propel growth in the cell based assays market value. Rising risk of chronic diseases, including cancer, diabetes, and epilepsy and growing awareness regarding the various advantages of cell-based assays over alternative technologies will also emerge as other important market growth determinants.
However, lack of the professionals and technological experts to run these instruments in the developing and underdeveloped economies will challenge the growth of cell based assays market in the forecast period mentioned above. Also, rigid, intellectual property rights, high cost of instruments and stringent regulations imposed on the application of such instruments will obstruct the market growth rate.
This cell based assays market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on cell based assays market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
North America Cell Based Assays Market Scope and Market Size
The cell based assays market is segmented on the basis of type, product and services, technology, application, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the cell based assays market is segmented into cell viability assay, cell proliferation assay, cytotoxicity assay, cell death assay and others.
- On the basis of product and services, the cell based assays market is segmented consumables, services, instruments and software.
- On the basis of technology, the cell based assays market is segmented into flow cytometry, label free detection, high content screening and high throughput screening.
- On the basis of application, the cell based assays market is segmented into drug discovery, basic research and others.
- On the basis of end user, the cell based assays market is segmented into pharmaceutical and biotechnology companies, academic and research institutions, contract research organizations, government organizations and others.
- On the basis of distribution channel, the cell based assays market is segmented into direct and indirect.
North America Cell Based Assays Market Country Level Analysis
The cell based assays market is analysed and market size insights and trends are provided by type, product and services, technology, application, end user and distribution channel as referenced above.
The countries covered in the cell based assays market report are U.S., Canada and Mexico.
U.S. in North America dominates the cell based assays market owing to the prevalence of advanced healthcare technologies, increased funding for research and development activities, and rise in cell-based assay applications.
The country section of the cell based assays market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The cell based assays market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the cell based assays market. The data is available for historic period 2010 to 2019.
Competitive Landscape and North America Cell Based Assays Market Share Analysis
The cell based assays market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to cell based assays market.
The major players covered in the cell based assays market report are Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories, Inc., GENERAL ELECTRIC COMPANY, Danaher, BD, QIAGEN, Promega Corporation., Agilent Technologies, PerkinElmer Inc., BioTek Instruments, Inc., BD, ATCC, Aurelia Bioscience Ltd, BioAgilytix Labs, BioVision Inc., Cell Signaling Technology, Inc., Cisbio, Enzo Biochem Inc., Eurofins Scientific, LakePharma, Inc., Lonza, Miltenyi Biotec, Xeno Diagnostics, LLC, Creative Bioarray, Geno Technology Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc. and Gilead Sciences, Inc., among other. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-